The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2022

Filed:

Oct. 16, 2018
Applicant:

Inventage Lab Inc., Seongnam-si, KR;

Inventor:

Ju Hee Kim, Seongnam-si, KR;

Assignee:

INVENTAGE LAB INC., Seongnam-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01J 13/06 (2006.01); A61K 9/00 (2006.01); B01J 19/00 (2006.01); A61K 9/16 (2006.01); B01F 33/302 (2022.01); B01F 33/30 (2022.01); B01F 33/3011 (2022.01); A61K 9/14 (2006.01); A61K 31/365 (2006.01); A61K 31/58 (2006.01); B01L 3/00 (2006.01); C08J 5/00 (2006.01); B01J 2/06 (2006.01); B01J 2/02 (2006.01);
U.S. Cl.
CPC ...
B01J 13/06 (2013.01); A61K 9/0019 (2013.01); A61K 9/146 (2013.01); A61K 9/1647 (2013.01); A61K 9/1682 (2013.01); A61K 31/365 (2013.01); A61K 31/58 (2013.01); B01F 33/30 (2022.01); B01F 33/302 (2022.01); B01F 33/3011 (2022.01); B01J 19/0093 (2013.01); B01L 3/502707 (2013.01); C08J 5/00 (2013.01); B01J 2/02 (2013.01); B01J 2/06 (2013.01); B01J 2219/00889 (2013.01); B01L 2200/0647 (2013.01); B01L 2300/0816 (2013.01); B01L 2300/161 (2013.01); C08J 2367/04 (2013.01);
Abstract

The present invention relates to extended release microparticles comprising a drug, and a preparation method therefor, and when the extended release microparticles comprising a drug are administered in order to replace conventional drugs that should be administered daily or monthly, the drug administration effect can be continuously maintained for one week to three months. In addition, the drug administration effect is maintained for a long time and, simultaneously, microparticles are prepared so as to have the average diameter of a fixed micro-size, and thus an effective drug concentration can be constantly maintained by controlling the release of the drug from the microparticles, and a foreign body sensation and pain can be reduced during drug administration since microparticles having a uniform size are included during application as an injectable drug.


Find Patent Forward Citations

Loading…